ArdorComm Media Group

Contact Us
Menu

COVID-19

EU Initiates Complaints Against Microsoft’s 365 Education Suite Over Privacy Concern

Leave a Comment / By / Education Community
News on Education 2 ArdorComm Media Group EU Initiates Complaints Against Microsoft's 365 Education Suite Over Privacy Concern

Microsoft is currently facing two complaints in the European Union (EU) regarding its online education software, 365 Education. According to a report by Reuters, the latest charges against the US-based tech giant have been brought to the Austrian privacy watchdog by the privacy advocacy group NOYB. The group has urged the Austrian Data Protection Authority to investigate these complaints and potentially impose a fine on Microsoft. What is Microsoft 365 Education Suite? During the COVID-19 pandemic, online educational programs gained popularity as schools transitioned to remote teaching. Microsoft’s 365 Education suite offers various tools for students, including Word, Excel, Microsoft Teams, PowerPoint, and Outlook. Complaints Against Microsoft’s 365 Education Suite First Complaint: The advocacy group NOYB alleged that Microsoft shifted the burden of complying with EU data privacy laws (GDPR) onto schools. According to NOYB, schools cannot adequately manage student data under these regulations. NOYB lawyer Maartje de Graaf stated: “Under the current system that Microsoft is imposing on schools, your school would have to audit Microsoft or give them instructions on how to process pupils’ data. Everyone knows that such contractual arrangements are out of touch with reality. This is nothing more but an attempt to shift the responsibility for children’s data as far away from Microsoft as possible.” Second Complaint: The second complaint centers around cookies installed in Microsoft’s 365 Education suite that advertisers use to track consumers. NOYB lawyer Felix Mikolasch expressed concerns: “Our analysis of the data flows is very worrying. Microsoft 365 Education appears to track users regardless of their age. This practice is likely to affect hundreds of thousands of pupils and students in the EU and EEA (European Economic Area).” EU’s Previous Warnings to Microsoft Last month, the EU warned Microsoft that it could impose a fine of up to 1% of its global annual revenue if it fails to provide requested information about the risks associated with its generative AI tools in the Bing search engine. In March, the EU asked tech giants, including Microsoft, to provide details on how they manage risks from AI tools. Microsoft has been accused of dodging questions about its “Copilot in Bing” and “Image Creator” features, which the EU fears may violate new laws by spreading misinformation and manipulating voters.  

Saudi Arabia Reports Three New MERS Cases, Highlighting Risks and Differences from COVID-19

Leave a Comment / By / Health & Wellness Community
News on Health 1 ArdorComm Media Group Saudi Arabia Reports Three New MERS Cases, Highlighting Risks and Differences from COVID-19

The Saudi health ministry has notified the World Health Organization (WHO) of three new Middle East Respiratory Syndrome (MERS) coronavirus cases in Riyadh, Saudi Arabia. Sadly, one of these cases resulted in death. All three individuals were male, aged between 56 and 60, with pre-existing health conditions. None of them were healthcare workers. This brings the total number of MERS cases reported in Saudi Arabia in 2024 to four, with two fatalities. Dr. Syed Abdul Aleem, a Pulmonology Consultant at CARE Hospitals in Musheerabad, Hyderabad, explains that MERS-CoV is a viral respiratory illness caused by the MERS strain of coronavirus. Unlike COVID-19, MERS tends to be more severe with a higher mortality rate but is less contagious. It is primarily transmitted from camels to humans, with limited human-to-human transmission. Risk factors for MERS-CoV include close contact with camels or living in endemic regions, along with underlying medical conditions such as diabetes or chronic lung disease. Symptoms are similar to COVID-19, including fever, cough, and shortness of breath, but MERS can progress to severe respiratory illness, leading to pneumonia and acute respiratory distress syndrome (ARDS). Some individuals may also experience gastrointestinal symptoms like diarrhea. Management involves supportive care, with severe cases requiring hospitalization and supportive measures like supplemental oxygen therapy and mechanical ventilation. There is no specific antiviral treatment for MERS, but prevention measures include avoiding close contact with camels, practicing good hand hygiene, and avoiding contact with sick individuals. This highlights the importance of understanding the differences between MERS and COVID-19 and taking appropriate precautions to prevent transmission and manage cases effectively.  

The Economic Wisdom of an Annual COVID-19 Vaccine: A Comprehensive Study

Leave a Comment / By / Blogs
Blog on Health 1 ArdorComm Media Group The Economic Wisdom of an Annual COVID-19 Vaccine: A Comprehensive Study

The COVID-19 pandemic has reshaped our lives in profound ways, influencing everything from our daily routines to global economies. As vaccination rates wane and governments reconsider their policies, questions arise regarding the necessity and benefits of an annual COVID-19 vaccine. A recent study published in The Journal of Infectious Diseases sheds light on this issue, exploring the economic and clinical advantages of an annual COVID-19 vaccination from an individual perspective. The study’s findings underscore the importance of ongoing vaccination efforts in mitigating the impact of COVID-19 on both personal health and finances. Despite decreasing morbidity and mortality rates, the economic value of annual vaccination remains significant, particularly for adults aged 18 to 64. The research employs a sophisticated Markov computational simulation model to assess the economic implications of annual COVID-19 vaccination, considering factors such as infection risk, clinical outcomes, and vaccine efficacy. Key findings from the study reveal that individuals, regardless of health insurance status, stand to benefit clinically and economically from annual COVID-19 vaccination. Notably, adults aged 50 to 64 experience the highest economic savings, emphasizing the importance of continued vaccination efforts among older populations. The study’s comprehensive approach provides valuable insights into the cost-benefit dynamics of annual COVID-19 vaccination, informing individual decision-making in an evolving pandemic landscape. As the world navigates the ongoing challenges of the COVID-19 pandemic, evidence-based research remains crucial in guiding public health policies and individual behaviors. The study’s implications extend beyond the realm of healthcare, highlighting the interconnectedness of health and economics in shaping societal well-being. By investing in annual COVID-19 vaccination, individuals can safeguard their health while making prudent financial decisions, contributing to a safer and more resilient future for all. In conclusion, the study underscores the wisdom of investing in an annual COVID-19 vaccine, both for personal health and economic prosperity. As governments and individuals alike consider the path forward in a post-pandemic world, the findings serve as a timely reminder of the enduring value of vaccination in protecting lives and livelihoods.  

Zell Education Launches Global Career Championship, Offering Financial Education Scholarships

Leave a Comment / By / Education Community
News on Education 4 1 ArdorComm Media Group Zell Education Launches Global Career Championship, Offering Financial Education Scholarships

Zell Education has unveiled the Global Career Championship, a scholarship program designed to empower students and professionals seeking to enhance their skills in finance and accounts. The initiative aims to provide a platform for individuals globally to upskill, fostering career growth in the competitive field of financial education. In a recent press release, Zell Education highlighted the program’s focus on offering opportunities for students and working professionals worldwide. The Global Career Championship invites participants to showcase their expertise and passion for finance, with the winner earning exclusive access to Zell Education’s advanced courses. The scholarship covers a spectrum of finance-related subjects, including ACCA, FRM, CFA, CMA, IFRS, and other finance and accounts courses. Notably, the winner will enjoy complimentary enrollment in these courses, with all associated global body fees and coaching fees fully covered. Pratham Barot, CEO and Co-Founder of Zell Education, expressed enthusiasm about the Global Career Championship, emphasizing its role in helping individuals acquire the necessary expertise to excel in their careers. Barot stated, “The Global Career Championship is our way of helping ambitious learners with the knowledge and resources they require to succeed.” This initiative underscores Zell Education’s commitment to fostering learning and development in the field of finance, providing a unique opportunity for individuals globally to advance their careers through top-notch educational offerings. Aspiring candidates eager to excel in finance and accounts are encouraged to participate in the Global Career Championship and leverage this scholarship program for professional growth.

Chinese Health Authorities Warn of Potential COVID-19 Rebound in January

Leave a Comment / By / Health & Wellness Community
News on Health 5 1 ArdorComm Media Group Chinese Health Authorities Warn of Potential COVID-19 Rebound in January

Chinese health authorities have issued a warning of a possible rebound in COVID-19 infections in January, despite a recent decline in patients at fever clinics since New Year’s Day. The National Health Commission spokesperson, Mi Feng, stated at a press briefing that while respiratory diseases, mainly influenza, are still prevalent, the COVID-19 infection rate remains relatively low. Recent data from the multi-channel monitoring system revealed a positive rate of COVID-19 testing below one percent in sentinel hospitals after the New Year’s Day holiday. Wang Dayan, director of the China National Influenza Center, expressed concern about the upward trend in the proportion of the JN.1 variant strain, indicating a potential resurgence. Experts anticipate a co-circulation of respiratory pathogens during the winter and spring, with influenza viruses dominating in the short term. Wang Dayan highlighted the potential for a COVID-19 rebound in January due to the continuous importation of the JN.1 variant, declining influenza, and a decrease in population immunity. The JN.1 variant is likely to become the dominant strain in China. Influenza B virus proportions have risen significantly in both southern and northern provinces, surpassing influenza A in some regions. Wang emphasized the need for early influenza vaccination, as the immune response from contracting influenza A does not protect against influenza B. Wang Guiqiang, director of the Department of Infectious Diseases at Peking University First Hospital, emphasized the peak season for respiratory infectious diseases in winter and the potential for repeated infections. He urged increased attention to early intervention and diagnosis, particularly for the elderly and those with underlying diseases, as COVID-19 or influenza infections could worsen underlying conditions.

Budget 2024: Pharma Industry Urges More Tax Breaks for R&D, Innovation, and Increased Healthcare Spending

Leave a Comment / By / Health & Wellness Community
News on Health 4 1 ArdorComm Media Group Budget 2024: Pharma Industry Urges More Tax Breaks for R&D, Innovation, and Increased Healthcare Spending

Amidst the anticipation surrounding the upcoming Union Budget on February 1, the healthcare and pharmaceutical industry has outlined a comprehensive wishlist for Budget 2024, aiming for policies that foster innovation, research and development (R&D), and increased healthcare spending. Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance, emphasized the need for conducive policies that offer direct and indirect tax benefits to pharmaceutical companies. The focus should be on critical areas such as innovation, R&D, and upgrading healthcare infrastructure. Jain highlighted the significance of continuous investments, especially in a sector with high risks and long gestation periods. Dr. Ashutosh Raghuvanshi, MD and CEO of Fortis Healthcare & President of NATHEALTH, called for a significant hike in healthcare spending to 2.5% of GDP. The proposals presented by NATHEALTH emphasize transformative changes to bridge regional healthcare disparities and strengthen the healthcare value chain. The aim is to enhance medical value travel, address MAT credit issues, and build local capabilities for healthcare services. Ameera Shah, Promoter and Managing Director of Metropolis Healthcare, underscored the importance of the upcoming budget in strengthening India’s healthcare ecosystem. Shah advocated for investments in critical areas like innovation, research, development, technology, and upgrading healthcare infrastructure. Additionally, she called for a 0% GST on diagnostic services, GST refunds on inputs, and rationalizing import tariffs on healthcare products to enhance accessibility and affordability. These recommendations collectively aim to position India as a reliable supplier of medicines and a custodian of global healthcare. The healthcare sector looks forward to policy stability, continuity, and transformative measures in the upcoming budget, recognizing the role it plays in combating present and future healthcare challenges. Source: CNBC-TV18

Delhi Reports First Case of JN.1 COVID Variant: Live Updates and Emerging Trends in India’s Pandemic Landscape

Leave a Comment / By / Health & Wellness Community
News on health 7 ArdorComm Media Group Delhi Reports First Case of JN.1 COVID Variant: Live Updates and Emerging Trends in India’s Pandemic Landscape

Delhi has reported its first case of the JN.1 COVID variant, as per live updates on the pandemic. The All India Institute of Medical Sciences (AIIMS) in Delhi has promptly issued guidelines in response to this new case. As of December 26, India has recorded a total of 109 JN.1 COVID variant cases, according to sources from the Health Ministry. The distribution of cases reveals 36 in Gujarat, 34 in Karnataka, 14 in Goa, 9 in Maharashtra, 6 in Kerala, 4 in Rajasthan, 4 in Tamil Nadu, and 2 in Telangana. Wednesday witnessed a spike in the daily COVID-19 cases in India, with 529 new infections reported in a single day. The active infection count in the country stands at 4,093, with three new fatalities documented within 24 hours – two in Karnataka and one in Gujarat. This surge in cases follows a period of relative decline, with daily case numbers dropping to double digits until December 5. The resurgence is attributed to the emergence of a new variant and cold weather conditions. Internationally, the World Health Organization (WHO) has classified JN.1 as a variant of interest, distinct from its parent lineage BA.2.86. However, the WHO has emphasized that, based on current evidence, the overall risk posed by JN.1 remains low. The classification of JN.1 as a variant of interest underscores the ongoing efforts to monitor and understand the evolution of the virus.

COVID-19 Update: Rising Cases, Advisory in Himachal, JN.1 Variant Spreads

Leave a Comment / By / Health & Wellness Community
News on Health 6 ArdorComm Media Group COVID-19 Update: Rising Cases, Advisory in Himachal, JN.1 Variant Spreads

Amid a surge in COVID-19 cases, several Indian states are urging citizens to adhere to coronavirus protocols. As of December 25, Kerala leads with 3,096 active cases, followed by Karnataka (436), Maharashtra (168), Gujarat (56), and Tamil Nadu (139). The Union Health Ministry reported 69 cases of the JN.1 COVID subvariant in the country. In response to the variant’s presence, Himachal Pradesh health officials issued an advisory. Chief medical officers are instructed to test individuals with COVID-19 symptoms, emphasizing vigilance. Dr. Sanjeev Kumar from Una recommended immediate testing for those with symptoms like cold, fever, or cough, while stressing the importance of mask-wearing. Karnataka Health Minister Dinesh Gundu Rao confirmed 34 cases of the JN.1 variant in the state, reassuring the public that the situation is under control. Deputy Chief Minister DK Shivakumar urged citizens not to panic, emphasizing that the health minister would provide updates. In a surprising turn, BJP MLA Basanagouda Patil Yatnal threatened to reveal a purported ₹40,000-crore “Covid scam” if expelled from the party. Yatnal alleges that the Karnataka BJP government, led by B S Yediyurappa, engaged in massive corruption during the peak of the COVID-19 pandemic. Delhi’s Health Minister Saurabh Bharadwaj stated that the city’s COVID positivity rate is around 1%. While advising caution during winter festivals, he assured the public that additional genome sequencing is being conducted. Meanwhile, a new COVID-19 case surfaced in Khurda district, Odisha, bringing the state’s total to three. All three individuals exhibit mild symptoms and are undergoing home treatment. Responding to the escalating cases, the Karnataka government’s coronavirus sub-committee implemented measures, including mandatory mask-wearing, home isolation, and caution against sending symptomatic children to schools. Dr. Shekhar C Mande, former Director-General of CSIR, emphasized the significance of disease surveillance in India, not only for COVID-19 but also for tracking the spread of various infections, including antimicrobial resistance. He highlighted the usefulness of surveillance methods such as wastewater analysis in detecting variants like JN.1. The World Health Organization (WHO) has labeled JN.1 as a ‘variant of interest,’ distinct from its counterpart BA.2.86. Despite this, WHO maintains that the risk from JN.1 remains low for now

Health Ministry Issues Alert on Covid-19 Subvariant JN.1: Guidelines and Concerns Amid Rising Cases

Leave a Comment / By / Health & Wellness Community
News on health 4 ArdorComm Media Group Health Ministry Issues Alert on Covid-19 Subvariant JN.1: Guidelines and Concerns Amid Rising Cases

The Indian government has issued an alert to states regarding the emergence of the new Covid-19 subvariant, JN.1, as cases continue to rise in Kerala and 15 cases have been detected in samples from Goa. The Health Ministry emphasized that it is not yet clear whether an infection caused by JN.1 produces different symptoms or is more severe than other variants. The ministry stated that there is currently no indication of increased severity from JN.1, and there is no evidence that it presents an increased risk to public health compared to other circulating variants. Experts, including Dr. GC Khilnani, reassured that the elderly and those with comorbidities are not at an increased risk compared to other variants. General precautions such as handwashing and avoiding crowded areas during the festive season are recommended. The existing treatment for COVID-19 is expected to be effective against JN.1, and updated COVID-19 vaccines are expected to provide increased protection. RT-PCR tests remain the most reliable method for detecting the new subvariant. As the festive season approaches, the Health Ministry stressed the importance of adhering to respiratory hygiene norms, including wearing masks in enclosed and crowded spaces, frequent handwashing, and social distancing. States, such as Karnataka, are taking additional measures, mandating face masks for the elderly and those with comorbidities. The Health Ministry is conducting intensified surveillance at various levels, including laboratories, communities, and sewage, to monitor and report cases of influenza-like illness and Severe Acute Respiratory Illness. The global concern over JN.1 is due to its immunity-evading capacity, leading to rapid spread, with outbreaks reported in the US, China, and Singapore. JN.1 is a descendant of the BA.2.86 lineage of SARS-CoV-2.

Apple employees are no longer compelled to wear masks at work

Leave a Comment / By / Human Resource Community
HR news 3rd August 2022 ArdorComm Media Group Apple employees are no longer compelled to wear masks at work

According to reports, Apple has informed its staff that wearing masks to work is no longer mandatory. However, if they feel safe doing so, they are free to wear masks. The employees are free to choose in accordance with their level of comfort, the particular circumstances and conditions in their respective locations, and the health authorities’ criteria. At most of its sites, Apple has reportedly instructed staff to respect individual decisions to mask up or not, and to not engage in any form of discrimination against those who choose to do so. Coincidentally, the COVID-19 BA.5 variant is spreading quickly throughout the US. According to media sources, more than 1.75 lakh cases have already been reported. Based on the drop in infections and hospitalizations, Los Angeles County in California has formally decided to repeal the mask mandate. The County’s 10 million residents would have been required to wear masks indoors, according to earlier plans by its health authorities. In the meantime, a Texas court has upheld the governor’s ban on mask requirements in schools, Greg Abbott. Abbott’s executive order forbade any governmental organisations, including universities and other academic institutions, from enforcing mask regulations. There were numerous demonstrations against this restriction, nevertheless. The prohibition was also the subject of a lawsuit by a group of students who claimed Texas State had violated the American Rescue Plan Act, the Rehabilitation Act, and the Disabilities Act by imposing it and that doing so endangered the lives of the students. However, the court said there was insufficient evidence to support the claim that the mask restriction put them at danger of catching COVID-19.